Stock MYLAN INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Mylan Inc Nasdaq

Equities

US6285301072

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Mylan Inc
Jul. 03 Viatris Divests Over-the-Counter Business to Cooper Consumer Health MT
Jul. 03 Cooper Consumer Health SAS completed the acquisition of Substantially All of the Over-the-Counter Business of Viatris Inc.. CI

Business Summary

Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.

Sales per Business

USD in Million2022Weight2023Weight Delta
Brands
63.7 %
9,890 60.8 % 9,801 63.7 % -0.90%
Generics
36.3 %
5,015 30.8 % 5,588 36.3 % +11.42%

Sales per region

USD in Million2022Weight2023Weight Delta
Developed Markets
37.0 %
5,844 35.9 % 5,700 37.0 % -2.46%
United States
23.1 %
3,947 24.3 % 3,552 23.1 % -10.00%
Emerging Markets
16.6 %
2,637 16.2 % 2,552 16.6 % -3.24%
China
12.3 %
1,951 12.0 % 1,889 12.3 % -3.19%
Japan, Australia and New Zealand
9.3 %
1,634 10.0 % 1,425 9.3 % -12.81%
Greater China
1.8 %
250 1.5 % 271 1.8 % +8.60%

Managers

Managers TitleAgeSince
Scott Smith CEO
 Chief Executive Officer 61 22-12-28
Abhijit Barve CTO
 Chief Tech/Sci/R&D Officer - -
Sanjeev Kumar Sethi COO
 Chief Operating Officer - 20-11-15
David Bayles CMP
 Compliance Officer - 20-11-15
Ramkumar V. Rayapureddy CTO
 Chief Tech/Sci/R&D Officer - -
Philippe Martin CTO
 Chief Tech/Sci/R&D Officer - Dec. 14
Rajiv Malik BRD
 Director/Board Member 63 20-11-15
Melissa Trombetta IRC
 Investor Relations Contact - 20-10-31
Bill Szablewski IRO
 Public Communications Contact - 20-11-15
Burt Park LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Melina Higgins CHM
 Chairman 56 20-11-15
Mark Parrish BRD
 Director/Board Member 68 20-11-15
Harry Korman BRD
 Director/Board Member 66 20-11-15
James Kilts BRD
 Director/Board Member 76 20-11-15
Elisha Finney BRD
 Director/Board Member 62 22-12-28
Robert Coury BRD
 Director/Board Member 63 20-11-15
Rajiv Malik BRD
 Director/Board Member 63 20-11-15
Scott Smith CEO
 Chief Executive Officer 61 22-12-28
JoEllen Dillon BRD
 Director/Board Member 60 20-11-15
Richard Mark BRD
 Director/Board Member 70 20-11-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,231,159,482 1,186,316,314 ( 96.36 %) 40,483,663 ( 3.288 %) 96.36 %

Shareholders

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
11.89 %
141,525,740 11.89 % 1 504 M $
BlackRock Advisors LLC
6.040 %
71,916,364 6.040 % 764 M $
STATE STREET CORPORATION
5.271 %
62,761,609 5.271 % 667 M $
T. Rowe Price International Ltd.
4.861 %
57,884,431 4.861 % 615 M $
Davis Selected Advisers LP
4.826 %
57,465,399 4.826 % 611 M $
Invesco Advisers, Inc.
2.624 %
31,243,535 2.624 % 332 M $
Geode Capital Management LLC
2.395 %
28,520,481 2.395 % 303 M $
Pacer Advisors, Inc.
2.219 %
26,415,181 2.219 % 281 M $
Deerfield Management Co. LP (Private Equity)
1.797 %
21,395,052 1.797 % 227 M $
Ameriprise Financial Services LLC
1.731 %
20,612,328 1.731 % 219 M $

Company contact information

Viatris, Inc.

Robert J. Coury Global Center 1000 Mylan Boulevard

15317, Canonsburg

+724 514 1800

http://www.viatris.com
address Mylan Inc

Group companies

NameCategory and Sector
Utah Acquisition Sub, Inc.
Logo Utah Acquisition Sub, Inc.

Utah Acquisition Sub, Inc.

Pharmaceuticals: MajorHealth Technology

Part of Viatris, Inc., Utah Acquisition Sub, Inc. is an American pharmaceutical company. The company is located in the US.

Pharmaceuticals: Major
Biosimilars Newco Ltd.
Logo Biosimilars Newco Ltd.

Biosimilars Newco Ltd.

Chemicals: SpecialtyProcess Industries

Part of Viatris, Inc., Biosimilars Newco Ltd. is a British company that manufactures organic chemicals. The company is located in the UK.

Chemicals: Specialty

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+62.66% 854B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.42% 636B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.37% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.16% 324B
ABBVIE INC. Stock AbbVie Inc.
+9.87% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.66% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+4.21% 230B
NOVARTIS AG Stock Novartis AG
+17.90% 228B
AMGEN INC. Stock Amgen Inc.
+14.86% 177B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VTRS Stock
  4. Stock
  5. Company Mylan Inc